AEYE Health and Ford Medical Join Forces to Make AI Eye Exams Accessible Nationwide
AEYE Health Partners with Ford Medical
In a groundbreaking collaboration between AEYE Health and Ford Medical, a new frontier in healthcare is being opened for diabetic patients across the nation. AEYE Health, renowned for its advancements in AI-powered retinal diagnostics, has joined forces with Ford Medical to make fully autonomous, reimbursable diabetic eye exam screenings available in pharmacies and non-acute care centers. This innovative initiative aims to facilitate early detection of diabetic retinopathy, a leading cause of blindness among working-age individuals.
Addressing the Diabetic Retinopathy Challenge
As diabetes prevalence continues to rise, so does the need for effective screening solutions. Diabetic retinopathy, while highly preventable, often goes undetected due to the lack of regular screenings among diabetic patients. Clinical guidelines recommend annual assessments, yet many individuals do not have regular access to eye specialists. AEYE Health's revolutionary product, AEYE-DS, addresses this critical gap by allowing pharmacies to provide on-site, non-invasive eye exams that yield immediate results without needing a specialist's involvement.
What sets AEYE-DS apart is its approval by the FDA, making it the only AI solution compatible with portable cameras. This compatibility is a game-changer for pharmacies, enabling them to add valuable services while enhancing patient care significantly. With just one image per eye, AEYE-DS generates accurate diagnostic results in under a minute, making diabetic eye screening convenient and efficient.
A Step Towards Healthcare Accessibility
The partnership with Ford Medical is a pivotal step in making these AI-driven diagnostic tools more widely available. Ford Medical is committed to supporting non-acute care providers by distributing AEYE Health's AI screening solutions and equipping pharmacies to conduct in-house eye exams. This strategy not only closes existing care gaps but also provides pharmacies with new revenue opportunities. Importantly, screenings through AEYE-DS are reimbursable under an existing CPT code, further incentivizing healthcare providers to integrate this technology.
Zack Dvey-Aharon, Ph.D., CEO and Co-founder of AEYE Health, expressed enthusiasm about the collaboration, stating, "By bringing AEYE-DS into pharmacies and non-acute centers, we're not only enhancing accessibility but also empowering patients to take charge of their health. We're dedicated to making early detection of diabetic retinopathy simpler and more effective to prevent blindness for millions at risk."
Scott Greenberg, Vice President of Sales at Ford Medical, commented, "This partnership underscores our commitment to improving healthcare delivery for non-acute providers. By facilitating early detection, we are not only enhancing patient wellness but also enabling providers to grow their services and impact in the community."
Highlighting Innovations at ThoughtSpot 2025
AEYE Health and Ford Medical will showcase AEYE-DS at the ThoughtSpot 2025 event from July 16–19 at MGM Grand in Las Vegas, NV. This annual gathering, hosted by Good Neighbor Pharmacy and Cencora, is a premier platform for pharmacy professionals to explore innovative solutions that contribute to clinical efficiency and business growth. At the event, attendees will experience a mock pharmacy setup where they can observe firsthand how AEYE-DS facilitates rapid diabetic eye exams without pupil dilation, showcasing its seamless integration into pharmacy operations.
The event serves as an opportunity for pharmacy owners, clinicians, and industry leaders to engage with the latest advancements in healthcare technology, emphasizing the importance of adopting tools that can help transform patient care while ensuring financial sustainability.
In Summary
Overall, the partnership between AEYE Health and Ford Medical represents a significant milestone in integrating AI-driven diagnostics into everyday healthcare settings. With the advent of AEYE-DS, pharmacists can take an active role in diabetes management and screening, helping patients access vital eye care services directly within their communities. As healthcare continues to evolve, collaborations like this are crucial for meeting the needs of patients and providers alike, fostering a future where preventive care is a standard of practice in all venues of medical service.